1. In this multicenter, phase 3 study of cystic fibrosis patients who were previously unresponsive to modulator regimens, triple-combination therapy ...
![In utero administration of ivacaftor averts multiorgan disease in ferret model of cystic fibrosis [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2019/04/The_fluorescent_microscopy_image_of_CFTR_tagged_with_EYFP-350x250.jpg)
1. A G551D missense mutation in the cystic fibrosis transmembrane conductance receptor (CFTR) is a genetic cause of cystic fibrosis ...
Effect of Oral Capsule – vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection The most efficacious means of reducing recurrent ...
1. Absolute change in predicted forced expiratory volume in 1 second (FEV1) improved significantly over a 4 and 8-week period ...
1. Thymosin α1 (Tα1), an immunomodulatory drug currently in use, decreased lung inflammation in a mouse model of cystic fibrosis ...
1. After adjusting for risk factors associated with survival, Canadian patients had a median age of survival that was 10 ...
1. In patients with cystic fibrosis, monthly use of non-viral pGM169/GL67A gene therapy was associated with a significant, but modest, ...
![Novel compound may correct pathological airway mucus in cystic fibrosis [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/03/clubbing-350x250.jpg)
1. Mucus from cystic fibrosis patients had a rope-like structure and high elasticity due to chemical cross-links between mucin proteins. ...
Originally published by Harvard Health. What Is It? Cystic fibrosis is an inherited disease. It causes cells to produce mucus ...
1. From 2000 to 2010, adjusted mortality for cystic fibrosis (CF) patients dropped by 17% (1.8% per year). 2. Median ...
